Upper gastrointestinal endoscopic findings in celiac disease at diagnosis : A multicenter international retrospective study

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..

BACKGROUND: Gastroduodenal endoscopy and biopsy following positive specific serology is considered the gold standard to diagnose celiac disease (CeD) in adults. Whether upper endoscopy helps detect comorbid conditions is unknown.

AIM: To investigate the prevalence of non-celiac endoscopic findings in patients in whom endoscopy was performed to confirm CeD diagnosis.

METHODS: This is an observational, descriptive, multicenter, retrospective study that reports endoscopic findings obtained in adult patients enrolled in local registries from four tertiary centers. We collected data reported on first endoscopy, indicated for investigation of CeD. Diagnosis of CeD was performed by histology (≥ Marsh 2 type mucosal damage) and specific serology. Two European and one North American center included biopsy-confirmed CeD following positive serology. A fourth center (South America) included symptomatic patients undergoing endoscopy, irrespective of CeD serology. The latter cohort included a non-CeD control group.

RESULTS: A total of 1328 patients (80% female; 35 years median age) were enrolled, of whom 95.6% had positive specific serology. In 135 patients, endoscopy revealed 163 abnormalities unrelated to CeD (prevalence: 10.1%). Erosive reflux esophagitis (6.4%), gastric erosions (2.0%), and suspicion of esophageal metaplasia (1.2%) were the most common findings. Biopsy-confirmed Barrett's esophagus was infrequent (0.2%). No endoscopic cancer was detected. Older patients (≥ 51 years of age) had a higher prevalence of endoscopic findings than those ≤ 50 (P < 0.01). Within the South American cohort, CeD was associated with a lower rate (8.2%) of comorbid endoscopic findings compared with controls (29.1%; P < 0.001). In the adjusted multivariate analysis of this cohort, having CeD was associated with a 72% reduction in the risk of any endoscopic abnormality (P < 0.0001), and having alarm symptoms was associated with a 37% reduction in the risk of finding at least one endoscopic lesion (P < 0.02).

CONCLUSION: In this large multicenter study, young adults with positive CeD serology had few comorbid endoscopic findings. Although patients over 51 years had a high prevalence of non-CeD gastroduodenal mucosal damage, no malignancy or premalignant lesions were found.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

World journal of gastroenterology - 28(2022), 43 vom: 21. Nov., Seite 6157-6167

Sprache:

Englisch

Beteiligte Personen:

Stefanolo, Juan Pablo [VerfasserIn]
Zingone, Fabiana [VerfasserIn]
Gizzi, Carolina [VerfasserIn]
Marsilio, Ilaria [VerfasserIn]
Espinet, María Luján [VerfasserIn]
Smecuol, Edgardo Gustavo [VerfasserIn]
Khaouli, Mark [VerfasserIn]
Moreno, María Laura [VerfasserIn]
Pinto-Sánchez, María I [VerfasserIn]
Niveloni, Sonia Isabel [VerfasserIn]
Verdú, Elena F [VerfasserIn]
Ciacci, Carolina [VerfasserIn]
Bai, Julio César [VerfasserIn]

Links:

Volltext

Themen:

Celiac disease
Concomitant endoscopic lesions
Journal Article
Malignancies
Multicenter Study
Multicenter study
Observational Study
Upper gastrointestinal endoscopy

Anmerkungen:

Date Completed 15.12.2022

Date Revised 15.12.2022

published: Print

Citation Status MEDLINE

doi:

10.3748/wjg.v28.i43.6157

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM34995481X